세계의 임상시험 공급 및 물류 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, Phase별, 치료 영역별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Clinical Trial Supply & Logistics Market Growth & Trends:

The global clinical trials supply & logistics market size is estimated to reach USD 6.72 billion by 2030, expanding at a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trial Supply & Logistics Market Report Highlights:

• In service segment, logistics & distribution dominated the market in 2024 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic
• Based on phase, The phase III segment accounted for the largest revenue share in 2024
• Based on therapeutic area, the cardiovascular diseases segment held the largest market share in 2024. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
• North America dominated the market with a revenue share of 38.33% in 2024.The region accounts for the highest number of clinical trials conducted among all regions, which is a major driver for growth of clinical trial supply and logistics market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Technological Advancements in Supply Chain
    • 3.3.1.2. Increasing R&D Investment by Pharmaceutical and Biopharmaceutical Firms
    • 3.3.1.3. Increasing Demand For Outsourcing Services Across The Developing Economies
    • 3.3.1.4. Expansion of Clinical Trial Sites
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Stringent Regulation Pertaining to Logistics
    • 3.3.2.2. Counterfeiting of Drugs
• 3.4. Technological Advancements
  • 3.4.1. Integration of AI and Digital Technologies
• 3.5. Pricing Model Analysis
• 3.6. Clinical Trials Volume Analysis, 2024
  • 3.6.1. Total Number of Clinical Trials, by Region (2024)
  • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL by SWOT Analysis
  • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supply & Logistics Market: Service Estimates & Trend Analysis

• 4.1. Clinical Trial Supply & Logistics Market, By Service: Segment Dashboard
• 4.2. Clinical Trial Supply & Logistics Market, By Service: Movement Analysis
• 4.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Logistics & Distribution
  • 4.4.1. Logistics & Distribution Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.5. Storage & Retention
  • 4.5.1. Storage & Retention Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.6. Packaging, Labeling, and Blinding
  • 4.6.1. Packaging, Labeling, and Blinding Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.7. Manufacturing
  • 4.7.1. Manufacturing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.8. Comparator Sourcing
  • 4.8.1. Comparator Sourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.9. Other Services
  • 4.9.1. Other Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Supply & Logistics Market: Phase Estimates & Trend Analysis

• 5.1. Clinical Trial Supply & Logistics Market, By Phase: Segment Dashboard
• 5.2. Clinical Trial Supply & Logistics Market, By Phase: Movement Analysis
• 5.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Phase, 2018 - 2030
• 5.4. Phase I
  • 5.4.1. Phase I Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.5. Phase II
  • 5.5.1. Phase II Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.6. Phase III
  • 5.6.1. Phase III Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.7. Phase IV
  • 5.7.1. Phase IV Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Supply & Logistics Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Clinical Trial Supply & Logistics Market, By Therapeutic Area: Segment Dashboard
• 6.2. Clinical Trial Supply & Logistics Market, By Therapeutic Area: Movement Analysis
• 6.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
• 6.4. Oncology
  • 6.4.1. Oncology Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.5. Cardiovascular Diseases
  • 6.5.1. Cardiovascular Diseases Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.6. Respiratory Diseases
  • 6.6.1. Respiratory Diseases Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.7. CNS and Mental Disorders
  • 6.7.1. CNS and Mental Disorders Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Supply & Logistics Market: End Use Estimates & Trend Analysis

• 7.1. Clinical Trial Supply & Logistics Market, By End Use: Segment Dashboard
• 7.2. Clinical Trial Supply & Logistics Market, By End Use: Movement Analysis
• 7.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By End Use, 2018 - 2030
• 7.4. Pharmaceuticals
  • 7.4.1. Pharmaceuticals Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.5. Biologicals
  • 7.5.1. Biologicals Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.6. Medical Device
  • 7.6.1. Medical Device Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Clinical Trial Supply & Logistics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Colombia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Colombia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Profiles
  • 9.2.1. Thermo Fisher Scientific Inc.
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. UPS Healthcare
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Piramal Pharma Solutions
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. DHL
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Parexel International
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. Almac Group
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Movianto
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. UDG Healthcare
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. FedEx
    • 9.2.9.1. Company Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Service Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Catalent, Inc.
    • 9.2.10.1. Company Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Service Benchmarking
    • 9.2.10.4. Strategic Initiatives